aids drug assistance programs: utilization, program restrictions and waiting lists ryan clary &...

37
AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance of State and Territorial AIDS Directors

Upload: nicole-bloomer

Post on 30-Mar-2015

218 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

AIDS Drug Assistance Programs: Utilization, Program Restrictions and

Waiting ListsRyan Clary & Michael Friedman, Project

InformAnn Lefert, National Alliance of State and

Territorial AIDS Directors

Page 2: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Overview of Presentation

• Key ADAP terms• Understanding ADAP statistics – how do they

help tell the story?• Current ADAP situation• ADAP “asks”• History of ADAP activism• Current advocacy opportunities• Small-group messaging work

Page 3: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

What are ADAPs?

All states receive Ryan White funds to provide FDA approved medications to low income individuals with HIV disease who have limited or no coverage to private insurance or Medicaid/Medicare. ADAPs may purchase insurance and wrap-around all other payers.

Page 4: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Key ADAP Terms

• Eligibility Criteria – ADAPs are allowed to set their own Federal Poverty Level (FPL) as their eligibility criteria. Current eligibility criteria range from 200% to 500% FPL. The bulk of ADAP clients have incomes at or below 200% FPL.

• Formulary – ADAP drug list that establishes the number of drugs available to ADAP clients. Each state sets their own formulary, but must have at least 1 drug from each therapeutic class.

Page 5: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Key ADAP Terms• Cost-containment measure – blanket term used to

describe access restrictions in an ADAP. Common cost-containment measures are:– Lowered financial eligiblity levels– Reduced formulary (taking drugs off the formulary)– Capped enrollment – no new clients can enter the program– ADAP waiting lists – clients have been placed on a waiting

list to receive drugs through ADAP– Expenditure caps – a limit on monthly or annual spending

on drugs per client– Client cost-sharing – a requirement that clients contribute

a portion of their drug costs. In states that have this currently – it is only targeting the highest-income clients

Page 6: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Key ADAP Terms

• Coordination of Benefits – activities undertaken to ensure that the appropriate costs are paid for by the responsible payer when multiple payers exist.

• Payer of Last Resort – by law, Ryan White programs are the payer of last resort. They can only pay for services if no other payers are available

Page 7: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Key ADAP Terms

• Patient Assistance Programs – a program generally run through a pharmaceutical manufacturer to provide free or greatly subsidized medications to indigent patients.

Page 8: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Statistics

• Sources for ADAP Statistics:– NASTAD ADAP Watch: www.nastad.org– NASTAD Annual ADAP Monitoring Report:– HIV/AIDS Bureau, Health Resources and Services

Administration: www.hab.hrsa.gov– Specific State websites – database of state

information can be found on NASTAD’s site: http://www.nastad.org/About/res_state_Directory.aspx

Page 9: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Statistics

• ADAP Watch– Provides information on current cost-containment

measures– ADAP Waiting Lists garner lots of attention, but

any cost-containment measure has chilling affect on programs

• National ADAP Monitoring Report– Provides in-depth information on all 57 ADAPs

including: funding, client demographics, client utilization, expenditure data, etc.

Page 10: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Statistics

• Client Demographics – Race/ethnicity– Age– Gender– Income Levels– Insurance Status

Page 11: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Clients Served, by Race/Ethnicity, June 2008

Page 12: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Clients Served, by Gender,June 2008

Page 13: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Clients Served, by Age,June 2008

Page 14: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Clients Served, by Income Level,June 2008

Page 15: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Clients Served, by Insurance Status,June 2008

Page 16: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Statistics

• The total ADAP budget in a state can be made up of many different components:– Federal ADAP earmark– ADAP supplemental funding (if eligible)– State general revenue – Part B base funding– Contributions from Part A grantees– Drug rebates

Page 17: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Part B ADAP EarmarkFY2000 – FY2010

Page 18: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

The National ADAP Budget, by Source, FY2003 and FY2008

Page 19: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Situation

• ADAPs are currently in crisis• 15 states have implemented or are

anticipating having to implement cost-containment measures other than waiting lists

• 10 states have ADAP waiting lists

Page 20: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP Waiting Lists and Cost-Containment, as of April 15, 2010

Page 21: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Situation• ADAP Waiting Lists, as of April 15, 2010• Total of 938 individuals in 10 states– Idaho: 26 individuals – Iowa: 69 individuals – Kentucky: 191 individuals – Montana: 17 individuals – North Carolina: 400 individuals – South Carolina: 48 individuals– South Dakota: 32 individuals – Tennessee: 61 individuals – Utah: 80 individuals – Wyoming: 14 individuals

Page 22: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Situation• ADAPs with other cost-containment measures since April 1, 2009

– Arizona: reduced formulary– Arkansas: reduced formulary, lowered FPL to 200%– Colorado: reduced formulary– Hawaii: individuals with CD4>350 not currently on ARV therapy

are not being enrolled (not pregnant women)– Iowa: reduced formulary– Kentucky: reduced formulary– Missouri: reduced formulary– North Carolina: reduced formulary– North Dakota: cap on Fuzeon– Utah: reduced formulary, lowered FPL to 250%– Washington: client cost sharing, reduced formulary (for

uninsured clients only)

Page 23: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Situation• ADAPs considering new/additional cost-containment

measures– Arizona: waiting list– Hawaii: waiting list– Illinois: waiting list, reduced formulary, lowered FPL, capped

enrollment, monthly expenditure cap– Kentucky: reduced formulary– Louisiana: capped enrollment– North Carolina: lowered FPL– North Dakota: waiting list, reduced formulary, capped

enrollment, annual expenditure cap– Oregon: waiting list, reduced formulary– South Dakota: reduced formulary– Wyoming: lowered FPL, annual expenditure cap

Page 24: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Asks

• ADAPs are in need of additional federal funding:– ADAPs need an emergency appropriation of $126

million in FY2010 funds– In FY2011 ADAPS need $370 million (includes $126 m)

• ADAPs are currently funded at $835 m in FY10• Additional FY10 funding would allow states to

eliminate waiting lists and other cost-containment measures and allow maintenance of programs.

Page 25: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Current ADAP Asks

• ADAPs are seeing a record number of people in need of their services due to the economic downturn. Individuals are losing their jobs, insurance and are increasingly in need of safety net services such as the Ryan White Program.

• In FY2009, ADAPs saw an average monthly growth of 1,271 clients. This is an increase of 80 percent from FY2008 when ADAPs experienced an average monthly growth of 706 clients.

Page 26: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

ADAP activism: 15 years of fighting for lifesaving meds

• National ADAP Working Group• ATAC’s SAVE ADAP Committee• National ADAP Coalition• aaa+• Numerous state-based efforts• SAVE California’s ADAP• SAVE America’s ADAPs – activism through

social networking

Page 27: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Your voice is needed more than ever

• We can’t let people fall through the cracks while we wait for health care reform

• Many ADAP advocates have burnt out/moved on. New leaders are needed

• Grassroots activism/personal stories have led to ADAP funding success in the past

• Obama Administration has said it needs to hear from community

Page 28: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

SAVE CALIFORNIA’S

ADAP

Page 29: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Save California’s ADAP Facebook

Page 30: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Save California’s ADAP

Rallies

Page 31: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Save California’s ADAP Action Alerts and Press Releases

Page 32: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

SAVE AMERICA’S

ADAPs

Page 33: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Save America’s ADAPs Facebook

Page 34: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Save America’s ADAPs Change.org Petition to Obama

Page 35: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

How you can make a difference

• Come to Save America’s ADAPs affinity session tomorrow

• Call, email, meet with your elected representatives

• Letters to editor• Rallies, press conferences• Join Save America’s ADAPs facebook page

Page 36: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

More actions

• Send an email to President Obama through change.org petition: http://tinyurl.com/adapletter

• Sign your organization to a letter urging President Obama to provide emergency ADAP funding. Email [email protected] for a copy.

Page 37: AIDS Drug Assistance Programs: Utilization, Program Restrictions and Waiting Lists Ryan Clary & Michael Friedman, Project Inform Ann Lefert, National Alliance

Contact Information

Ann Lefert Ryan ClaryNASTAD Project InformP: 202.434.7138 P: 415.558.8669 [email protected] [email protected]

Michael FriedmanProject Inform

[email protected]